Roadmap Reassurance: Social media chatter centers on NVIDIA's firm denial of any delays to its Kyber AI system. Analysts note that the hardware roadmap appears intact amid ongoing data center strength. Price action shows the stock testing key moving averages with light volume.
Market Sentiment Shift: Observers highlight persistent concerns over Blackwell timelines even as long-term AI capital expenditure themes hold firm. Recent trading patterns reflect cooling momentum and some consolidation around the 200-day average. Broader discussions tie NVIDIA to related tech names amid evolving narratives.
Note: This discussion summary was generated from an AI condensation of post data.
NVIDIA Insider Trading Activity
NVIDIA insiders have traded $NVDA stock on the open market 88 times in the past 6 months. Of those trades, 0 have been purchases and 88 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- MARK A STEVENS has made 0 purchases and 7 sales selling 2,106,682 shares for an estimated $445,605,062.
- AJAY K PURI (EVP, Worldwide Field Ops) has made 0 purchases and 9 sales selling 1,000,000 shares for an estimated $183,002,962.
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 60 sales selling 157,930 shares for an estimated $28,137,521.
- AARTI S. SHAH has made 0 purchases and 3 sales selling 19,000 shares for an estimated $3,357,549.
- STEPHEN C NEAL sold 15,500 shares for an estimated $3,343,863
- DONALD F JR ROBERTSON (Principal Accounting Officer) has made 0 purchases and 6 sales selling 5,396 shares for an estimated $942,944.
- JOHN DABIRI has made 0 purchases and 2 sales selling 3,629 shares for an estimated $689,189.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
NVIDIA Revenue
NVIDIA had revenues of $81.6B in Q1 2027. This is an increase of 85.23% from the same period in the prior year.
You can track NVDA financials on Quiver Quantitative's NVDA stock page.
You can access data on NVDA stock through the Quiver Quantitative API.
NVIDIA Congressional Stock Trading
Members of Congress have traded $NVDA stock 21 times in the past 6 months. Of those trades, 6 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
- REPRESENTATIVE DANIEL MEUSER has traded it 6 times. They made 0 purchases and 6 sales worth up to $90,000 on 05/27, 04/24, 03/25, 02/25, 01/30, 01/14.
- SENATOR SHELDON WHITEHOUSE has traded it 4 times. They made 0 purchases and 4 sales worth up to $530,000 on 05/08, 01/09.
- REPRESENTATIVE JOHN MCGUIRE has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/15, 01/30 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 03/13, 01/30 and 2 sales worth up to $30,000 on 04/14, 03/25.
- REPRESENTATIVE LIZZIE FLETCHER sold up to $15,000 on 04/08.
- REPRESENTATIVE TIM MOORE sold up to $50,000 on 03/24.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 03/19.
- REPRESENTATIVE NANCY PELOSI purchased up to $500,000 on 01/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
NVIDIA Hedge Fund Activity
We have seen 2,654 institutional investors add shares of NVIDIA stock to their portfolio, and 2,337 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP removed 125,140,953 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $21,389,091,686
- CARDANO RISK MANAGEMENT B.V. removed 70,049,522 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $11,972,864,300
- SG AMERICAS SECURITIES, LLC removed 37,810,007 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,462,486,396
- FMR LLC added 22,789,685 shares (+2.3%) to their portfolio in Q1 2026, for an estimated $3,895,212,960
- CAPITAL RESEARCH GLOBAL INVESTORS added 21,474,958 shares (+12.5%) to their portfolio in Q1 2026, for an estimated $3,670,499,821
- MORGAN STANLEY added 19,220,362 shares (+5.9%) to their portfolio in Q1 2026, for an estimated $3,285,144,273
- BLACKROCK, INC. removed 18,279,710 shares (-0.9%) from their portfolio in Q1 2026, for an estimated $3,124,368,033
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
NVIDIA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 05/21/2026
- Benchmark issued a "Buy" rating on 03/31/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
To track analyst ratings and price targets for NVIDIA, check out Quiver Quantitative's $NVDA forecast page.
NVIDIA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 27 analysts offer price targets for $NVDA in the last 6 months, with a median target of $307.0.
Here are some recent targets:
- Jack Zhou from China Renaissance set a target price of $319.0 on 06/05/2026
- N. Quinn Bolton from Needham set a target price of $270.0 on 06/02/2026
- Gil Luria from DA Davidson set a target price of $300.0 on 06/01/2026
- Ivan Feinseth from Tigress Financial set a target price of $425.0 on 05/27/2026
- Srini Pajjuri from RBC Capital set a target price of $270.0 on 05/21/2026
- John Vinh from Keybanc set a target price of $310.0 on 05/21/2026
- Cody Acree from Benchmark set a target price of $335.0 on 05/21/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
